Aman M G, White A J
Nisonger Center, Ohio State University.
J Autism Dev Disord. 1988 Sep;18(3):355-66. doi: 10.1007/BF02212192.
Eleven residents receiving long-term thioridazine treatment were studied while receiving their previous dose, standardized low and high doses (1.25 and 2.50 mg/kg per day), and placebo conditions. For theoretical reasons, subjects were also classified by degree of stereotypic behavior on the Fairview Problem Behavior Checklist (Barron & Sandman, 1983). Ratings of hyperactivity and self-injury were significantly lower during the higher as compared with the lower dose condition. Subjects classified as in the high-stereotypy group had significantly and substantially higher levels of maladaptive behavior on several other clinical variables. When all four drug conditions were compared, no significant drug effects were detected. However, high-stereotypy subjects responded significantly better to the drug than low-stereotypy subjects on ratings of Lethargy/Social Withdrawal and Hyperactivity on the Aberrant Behavior Checklist (Aman, Singh, Stewart, & Field, 1985a). The findings were related to previous dosage research and the literature on stereotypic behavior.
对11名接受长期硫利达嗪治疗的住院患者进行了研究,他们分别接受之前的剂量、标准化的低剂量和高剂量(每天1.25毫克/千克和2.50毫克/千克)以及安慰剂治疗。出于理论原因,还根据《美景问题行为清单》(巴伦和桑德曼,1983年)对受试者的刻板行为程度进行了分类。与低剂量条件相比,高剂量条件下的多动和自我伤害评分显著更低。被归类为高刻板行为组的受试者在其他几个临床变量上的适应不良行为水平显著更高。当对所有四种药物条件进行比较时,未检测到显著的药物效应。然而,在《异常行为清单》(阿曼、辛格、斯图尔特和菲尔德,1985年a)的嗜睡/社交退缩和多动评分方面,高刻板行为受试者对药物的反应明显优于低刻板行为受试者。这些发现与之前的剂量研究以及关于刻板行为的文献相关。